Thrombotic thrombocytopenic purpura following coronary artery bypass graft surgery: Prospective observations of an emerging syndrome

Journal of Clinical Apheresis

Volumn 12, Issue 4, 1997, Pages 159-164

  Pavlovsky, Miguel ^a   Weinstein, Robert ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Plasma exchange; Post operative complications; Thrombocytopenia

Indexed keywords

AMINOCAPROIC ACID; APROTININ;

ADULT; AGED; ARTICLE; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; FEMALE; HEMODYNAMIC PARAMETERS; HUMAN; MALE; PLASMAPHERESIS; POSTOPERATIVE COMPLICATION; SURVIVAL RATE; THROMBOTIC THROMBOCYTOPENIC PURPURA;

AGED; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 0031455836     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1101(1997)12:4<159::AID-JCA1>3.0.CO;2-9     Document Type: Article

References (49)

1. Moschowitz E: Acute febrile pleiochromic anemia with hyaline thrombosis of terminal arterioles and capillaries: an undescribed disease. Arch Intern Med 36:89-93, 1925.
2. Amorosi EL, Ultman JE: Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine (Baltimore) 45:139-159, 1966.
3. Ridolfi RL, Bell WR: Thrombotic thrombocytopenic purpura: report of 25 cases and review of the literature. Medicine (Baltimore) 60:413-428, 1981.
4. Ruggenenti P, Remuzzi G: Thrombotic thrombocytopenic purpura and related disorders. Hematol Oncol Clin North Am 4:219-241, 1990.
5. Ruggenenti P, Remuzzi G: The pathophysiology and management of thrombotic thrombocytopenic purpura. Eur J Haematol 56:191-207, 1996.
6. Kwaan HC: Clinicopathologic features of thrombotic thrombocytopenic purpura. Semin Hemtol 24:71-81, 1987.
7. Bukowski RM, Hewlett JS, Harris JW, Hoffman GC, Battle JD Jr, Silverblatt E, Yang IY: Exchange transfusions in the treatment of thrombotic thrombocytopenic purpura. Semin Hematol 13:219-232, 1976.
8. Shepard KV, Bukowski RM: The treatment of thrombotic thrombocytopenic purpura with exchange transfusions, plasma infusions and plasma exchange. Semin Hematol 24:178-193, 1987.
9. Bukowski RM, King JW, Hewlett JS: Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura. Blood 50:413-417, 1977.
10. Myers TJ, Wakem CJ, Ball ED, Tremont SJ: Thrombotic thrombocytopenic purpura: combined treatment with plasmapheresis and antiplatelet agents. Ann Intern Med 92:149-155, 1980.
11. Lichtin AE, Schreiber AD, Hurwitz S, Willoughby L, Silberstein LE: Efficacy of intensive plasmapheresis in thrombotic thrombocytopenic purpura. Arch Intern Med 147:2122-2126, 1987.
12. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA, and the Canadian Apheresis Study Group: Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325:393-397, 1991.
13. Bell WR, Braine HG, Ness PM, Kickler TS: Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. N Engl J Med 325:398-403, 1991.
14. Dawson RB, Brown JA, Mahalati K, Sapsiri S, Pearlman S, Gulden D, Bilenki L, Wenk RE: Durable remissions following prolonged plasma exchange in thrombotic thrombocytopenic purpura. J Clin Apheresis 9:112-115, 1994.
15. Byrnes JJ, Khurana M: Treatment of thrombotic thrombocytopenic purpura with plasma. N Engl J Med 297:1386-1389, 1977.
16. Lian EC-Y, Byrnes JJ, Harkness DR: Two successful pregnancies in a woman with chronic thrombotic thrombocytopenia treated by plasma infusion. Am J Hematol 16:287-292, 1982.
17. Walker BK, Ballas SK, Martinez J: Plasma infusion of thrombotic thrombocytopenic purpura during pregnancy. Arch Intern Med 140:981-983, 1980.
18. McCrae KR, Samuels P, Schreiber AD: Pregnancy-associated thrombocytopenia, pathogenesis and management. Blood 80: 2697-2714, 1992.
19. Leaf AN, Laubenstein LJ, Raphael B, Hochster H, Baez L, Karpatkin S: Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 (HIV-1) infection. Ann Intern Med 109:194-197, 1988.
20. Nair JM, Bellevue R, Bertoni M, Dosik H: Thrombotic thrombocytopenic purpura in patients with the acquired immunodeficiency syndrome (AIDS)-related complex. A report of two cases. Ann Intern Med 109:209-212, 1988.
21. Laszlo MH, Alvarez A, Feldman F: The association of thrombotic thrombocytopenic purpura and disseminated lupus erythematosus: report of a case Ann Intern Med 42:1308-1320, 1955.
22. Levine S, Shearn MA: Thrombotic thrombocytopenic purpura and systemic lupus erythematosus. Arch Intern Med 113:826-836, 1964.
23. Dekker A, O'Brien ME, Cammarata RJ: The association of thrombotic thrombocytopenic purpura with systemic lupus erythematosus: a report of two cases with successful treatment of one. Am J Med Sci 267:243-249, 1974.
24. Morey DA, White JB, Daily WM: Thrombotic thrombocytopenic purpura diagnosed by a random lymph node biopsy. Arch Intern Med 98:821-823, 1956.
25. Benitez L, Mathews M, Mallory G: Platelet thrombosis with polyarteritis nodosa: Report of a case. Arch Pathol 77:116-125, 1964.
26. Lohrmann HP, Adam W, Heymer B, Kubanek B: Microangiopathic hemolytic anemia in metastatic carcinoma. Report of eight cases. Ann Intern Med 79:368-375, 1973.
27. Lyman NW, Michaelson R, Viscuso RL, Winn R, Mulgaonakar S, Jacobs MG: Mitomycin induced hemolytic uremic syndrome. Successful treatment with corticosteroids and intense plasma exchange. Arch Intern Med 143:1617-1618, 1983.
28. Murgo AJ: Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents. Semin Hematol 24: 161-177, 1987.
29. Byrnes JJ, Baquerizo H, Gonzalez M, Hensely GT: Thrombotic thrombocytopenic purpura subsequent to acute myelogenous leukemia chemotherapy. Am J Hematol 21:299-304, 1986.
30. Walker RW, Rosenblum MK, Kempin SJ, Christian MC: Carboplatin-associated thrombotic microangiopathic hemolytic anemia. Cancer 64:1017-1020, 1989.
31. Shulman H, Striker G, Dees HJ, Kennedy M, Storb R, Thomas ED: Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury. N Engl J Med 305:1392-1395, 1981.
32. Hebert D, Sibley RK, Mauer SM. Recurrence of hemolytic uremic syndrome in renal transplant recipients. Kidney Int 19:S51-S58, 1986.
33. Dzik WH, Georgi BA, Khettry U, Jenkins RL: Cyclosporine-associated thrombotic thrombocytopenic purpura following liver transplantation - successful treatment with plasma exchange. Transplantation 44:570-572, 1987.
34. Valbonesi M, Valente U, Pellicci R, Piri C, Ferrari M, Frisoni R, Zia S, Quarantino S, Fella M: Thrombotic microangiopathy of the miscellaneous secondary type responding to plasma exchange in a liver transplant recipient. Int J Artif Org 11:131-133, 1988.
35. Hochstetler LA, Flanigan MJ, Lager DJ: Transplant-associated thrombotic microangiopathy: the role of IgG administration as initial therapy. Am J Kidney Dis 23:444-450, 1994.
36. Hirsh LF: Vasculitis, thrombotic thrombocytopenic purpura, and stroke after aneurysm surgery. Surg Neurol 17:426-428, 1982.
37. Chang JC, Shipstone A, Llenado-Lee MA: Postoperative thrombotic thrombocytopenic purpura following cardiovascular surgeries. Am J Hematol 53:11-17, 1996.
38. Cuttner J: Thrombotic thrombocytopenic purpura: a ten-year experience. Blood 56:302-306, 1980.
39. Weinstein R: Prevention of citrate reactions during therapeutic plasma exchange by constant infusion of calcium gluconate with the return fluid. J Clin Apheresis 11:204-210, 1996.
40. Kantrowitz A, Wasfie T, Freed PS, Rubenfire M, Wajszczuk W, Schork MA: Intraaortic balloon pumping 1967 through 1982: Analysis of complications in 33 patients. Am J Cardiol 57:976-983, 1986.
41. Freed PS, Wasfie T, Zado B, Kantrowitz A: Intraaortic balloon pumping for prolonged circulatory support. Am J Cardiol 61:554-557, 1988.
42. Isner JM, Cohen SR, Virmani R, Lawrinson W, Roberts WC: Complications of the intraaortic balloon counterpulsation device: clinical and morphologic observations in 45 necropsy patients. Am J Cardiol 45:260-268, 1980.
43. Arom KV, Emery RW: Decreased postoperative drainage with addition of ∈-amino caproic acid before cardiopulmonary bypass. Ann Thorac Surg 57:1108-1113, 1994.
44. Royston D: Aprotinin in patients having coronary artery bypass graft surgery. Curr Opin Cardiol 10:591-596, 1995.
45. Primack C, Walenga JM, Koza MJ, Shankey TV, Pifarré R: Aprotinin modulation of platelet activation in patients undergoing cardiopulmonary bypass operations. Ann Thoracic Surg 61:1188-1193, 1996.
46. Hill GE, Springall DR, Robbins RA: Aprotinin is associated with a decrease in nitric oxide production during cardiopulmonary bypass. Surgery 121:449-455, 1997.
47. Wada H, Kaneko T, Ohiwa M, Tanigawa M, Tamaki S, Minami N, Takahashi H, Deguchi K, Nakano T, Shirakawa S: Plasma cytokine levels in thrombotic thrombocytopenic purpura. Am J Hematol 40:167-170, 1992.
48. Noris M, Ruggenenti P, Todeschini M, Figliuzzi M, Macconi D, Zoja C, Paris S, Gaspari F, Remuzzi G: Increased nitric oxide formation in recurrent thrombotic microangiopathies: A possible mediator of microvascular injury. Am J Kid Dis 27:790-796, 1996.
49. Mitra D, Jaffe EA, Weksler B, Hajjar KA, Soderland C, Laurence J: Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells. Blood 89:1224-1234, 1997.